Call Us + 33 1 84 88 31 00

Article L1123-7-1 of the French Public Health Code

Any sponsor based in France who plans to carry out research involving the human person in a non-EU country may submit its project to a committee for the protection of individuals. The Committee for the Protection of Individuals gives its opinion on the conditions for the validity of the research with regard to article L. 1121-2 and I of article L. 1123-7.

Read More »

Article L1123-7-2 of the French Public Health Code

When the National Agency for the Safety of Medicines and Health Products, the High Authority for Health, the Minister for Health or the European Medicines Agency refers a non-interventional research project involving a medicinal product which has been granted a marketing authorisation to the Committee for the Protection of Individuals for an opinion, it shall give the opinion referred to in Article L. 1123-7 solely with regard to the requirements…

Read More »

Article L1123-8 of the French Public Health Code

No one may carry out any research mentioned in 1° of Article L. 1121-1 without authorisation from the competent authority issued within a period set by regulation. If the competent authority informs the sponsor in a letter, stating the reasons, that it has objections to the implementation of the research, the sponsor may modify the content of its research project and submit this new request to the competent authority. This…

Read More »

Article L1123-9 of the French Public Health Code

After the start of the research, any substantial modification of the research on the initiative of the sponsor must obtain a favourable opinion from the Committee prior to its implementation and, in the case of research mentioned in 1° of Article L. 1121-1, authorisation from the competent authority. In this case, the Committee ensures that a new consent is obtained from the persons participating in the research if this is…

Read More »

Article L1123-10 of the French Public Health Code

For each type of research involving the human person, the investigator records the adverse events or abnormal analysis results defined in the protocol as decisive for the evaluation of safety, keeps a documentary record of them and notifies them to the sponsor. The notification procedures are defined by decree. It informs the sponsor of all serious adverse events occurring in participants, unless the protocol states otherwise. The sponsor shall notify…

Read More »

Article L1123-11 of the French Public Health Code

The competent authority may, at any time, ask the sponsor for additional information about the research. If there is a risk to public health or if the sponsor fails to respond, or if the competent authority considers that the conditions under which the research is being carried out no longer correspond to the conditions indicated in the application for authorisation referred to in Article L. 1123-8 or do not comply…

Read More »

Article L1123-12 of the French Public Health Code

I.-The competent authority for the research involving the human person provided for in article L. 1121-1 is the Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products). II-The Agency makes its decision with regard to the safety of persons who take part in the research referred to in 1° of article L. 1121-1, by considering : 1°…

Read More »

Article L1123-14 of the French Public Health Code

The procedures for applying the provisions of this chapter are determined by decree in the Conseil d’Etat, and in particular : 1° The composition and conditions of approval, financing, operation and appointment of the members of the Committees for the Protection of Individuals, as well as the nature of the information that must be communicated to them by the sponsor and on which they are called to give their opinion;…

Read More »

Article L1123-15 of the French Public Health Code

Subject to the provisions of this chapter, the provisions of chapters III, V and VI of this title apply respectively to research involving the human person, clinical investigations and performance studies which are classified as a national defence secret within the meaning ofarticle 413-9 of the Criminal Code and which are carried out for protection purposes. Such research, clinical investigations and performance studies are referred to as “research, clinical investigations…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.